Mechanism of Cholesterol Deposition in Bruch’s Membrane

  • Upload
    fola

  • View
    20

  • Download
    0

Embed Size (px)

DESCRIPTION

Mechanism of Cholesterol Deposition in Bruch’s Membrane. Christine A. Curcio, Ph.D. Department of Ophthalmology School of Medicine University of Alabama. Outline. Conclusion Intro to apoB/MTP system; role in atherosclerosis Evidence for an intra-ocular apoB lipoprotein Conclusion & models. - PowerPoint PPT Presentation

Citation preview

  • Mechanism of Cholesterol Deposition in Bruchs MembraneChristine A. Curcio, Ph.D.Department of OphthalmologySchool of MedicineUniversity of Alabama

    20051028, Curcio-2

  • OutlineConclusionIntro to apoB/MTP system; role in atherosclerosisEvidence for an intra-ocular apoB lipoproteinConclusion & models

    20051028, Curcio-2

  • ReferencesCurcio CA, Millican CL, Bailey T, Kruth HS: Accumulation of cholesterol with age in human Bruch's membrane, Invest. Ophthalmol. Vis. Sci. 2001, 42:265-274Malek G, Li C-M, Guidry C, Medeiros NE, Curcio CA: Apolipoprotein B in cholesterol-containing drusen and basal deposits in eyes with age-related maculopathy, Am. J. Pathol. 2003, 162:413-425Ruberti JW, Curcio CA, Millican CL, Menco BP, Huang JD, Johnson M: Quick-freeze/deep-etch visualization of age-related lipid accumulation in Bruch's membrane, Invest Ophthalmol Vis Sci 2003, 44:1753-1759.Li C-M, Presley JB, Zhang X, Dashti N, Chung BH, Medeiros NE, Guidry C, Curcio CA: Retina expresses microsomal triglyceride transfer protein: implications for age-related maculopathy, J. Lipid Res. 2005, 46:628 - 640Curcio CA, Presley JB, Millican CL, Medeiros NE: Basal deposits and drusen in eyes with age-related maculopathy: evidence for solid lipid particles, Exp Eye Res 2005, 80:761-775Li CM, Chung BH, Presley JB, Malek G, Zhang X, Dashti N, Li L, Chen J, Bradley K, Kruth HS, Curcio CA: Lipoprotein-like particles and cholesteryl esters in human Bruch's membrane: initial characterization, Invest Ophthalmol Vis Sci 2005, 46:2576-2586Curcio CA, Presley JB, Medeiros NE, Malek G, Avery DV, Kruth HS: Esterified and unesterified cholesterol in drusen and basal deposits of eyes with age-related maculopathy, Exp Eye Res 2005, in press:

    20051028, Curcio-2

  • HypothesisAge-related maculopathy, like coronary artery disease, involves the Response-to-Retention of apolipoprotein B-containing lipoprotein particles in a vascular intima, with the twist that the apo B-containing lipoprotein comes largely from the RPE rather than plasma.

    20051028, Curcio-2

  • Lipids in Bruchs MembraneHolz, Sheraidah, Pauleikhoff, & Bird (1994) Arch. Ophthalmol. 112: 402.Sheraidah, Steinmetz, Maguire, Pauleikhoff, Marshall, & Bird (1993). Ophthalmology 100: 47.Pauleikhoff, Harper, Marshall, & Bird (1990) Ophthalmology 97:171

    20051028, Curcio-2

  • Coronary Artery Disease:a Model for ARMWe should seek not only molecules of interest but a testable hypothesis that accounts for the overall trajectory of ARMPrincipal lesions (drusen and basal linear deposit) are in a vessel wall outside the blood-retina barrierA disease featuring extracellular lipid deposition in a vessel wall should be guided by research on coronary artery disease

    20051028, Curcio-2

  • Lipoprotein ClassesVance et al, Biochemistry of Lipids, Lipoproteins and Membranes 2002; nmnmnmnmnm

    20051028, Curcio-2

  • CholesterolFree (unesterified, UC)A component of all eukaryotic membranesNot metabolized by cells but turned over and released to circulating lipoproteins for hepatic clearance via bile salts Reverse cholesterol transportBound by an ester linkage to a fatty acid at 3-b OH group (esterified, EC)Intracellular storage Transport

    20051028, Curcio-2

  • Lipoprotein MetabolismLusis et al. Circulation.2004;110:1868

    20051028, Curcio-2

  • ApoB

    1 gene/ 2 proteins/ 1 molecule per particlemRNA editing; stop-codon at 2153 for apo B-48ApoB-100/ 4536 a.a./ liver/ VLDLApoB-48/ 2153 a.a. / intestine/ chylomicron5 domains in apoB-100 a-amphipathic, b-sheet, globularStructurally related to vitellogenin, an egg yolk proteinLipidation required for secretionDegraded via ubiquitin-proteosomeInsoluble when delipidatedFunction: delivery of TG (fuel)UniqueOnly non-exchangeable apolipoproteinIn mice, only apolipoprotein whose absence or dysfunction is fatalSegrest, Jones, De Loof, Dashti J Lipid Res 2001, 42:1346

    20051028, Curcio-2

  • MTP and Lipoprotein AssemblyMicrosomal triglyceride transfer proteinCells that express apo B without MTP cannot secrete lipoproteinsAll cells expressing MTP secrete lipoproteins Functional heterodimer in ERLarge (97KD)Small (55KD, protein disulfide isomerase)Transfers neutral lipid (TG, EC)Required for initial lipidation of apo BRole in subsequent steps under studyLoss of functional MTP protein: abetalipoproteinemiaSegrest et al., J Lipid Res 1999, 40:1401

    20051028, Curcio-2

  • Response to Retention Hypothesis

    Williams & Tabas. ATVB 1995, 15:551Figure after Proctor et al. Curr Opin Lipidol 2002, 13:461.

    20051028, Curcio-2

  • Esterified Cholesterolin Bruch's MembraneFilipin fluorescence, digital microscopy, normal eyesCurcio et al., IOVS 42:265, 2001

    20051028, Curcio-2

  • Bruchs Membrane Cholesterol* x 1000 nmol/g dry wtEnzymatic fluorimetric assay; chloroform/ methanol extracts; mechanically isolated Bruchs membrane; preserved normal eyesCurcio et al., IOVS 42:265, 2001 * x 1000 nmol/ gm

    20051028, Curcio-2

    Region

    Tissue

    N

    EC*

    %EC/TC

    Macula

    Bruch's

    10

    39.1

    59.6

    Retina

    7

    2.0

    3.6

    Choroid

    7

    7.4

    15.0

    Periphery

    Bruch's

    3

    8.3

    26.9

    Vessels included

    % of EC Recovered

    Enrichment

    (vs Plasma)

    Choriocapillaris

    2.5%

    40-fold

    Choriocapillaris+veins

    6.1%

    17-fold

  • Esterified Cholesterol-rich ParticlesSolid 100 nm particlesExtractable by chloro/ methIncrease with ageOccupy >30% of Bruchs in eyes > 60 yearsDense band external to RPE basal lamina in eyes > 60 yrConventional TEMLipid-preserving (OTAP)OTAP = osmium tannic acid p-phenylenediamine post-fixationCurcio et al., IOVS 42:265, 2001

    20051028, Curcio-2

  • Lipid Wall in Inner BruchsRuberti, Curcio, Millican, Menco, Huang, Johnson, IOVS 44:1753 (2003)

    20051028, Curcio-2

  • Particle StructureRuberti, Curcio, Millican, Menco, Huang, Johnson IOVS 44:1753 (2003)

    20051028, Curcio-2

  • Solid Particles in BlamDCurcio, Presley, Millican, Medeiros, Exp. Eye Res., 80:761-775

    20051028, Curcio-2

  • Lipid Particles in Lesions2% osmium and osmium tannic acid p-phenylenediamine post-fixation methods. Curcio, Presley, Millican, Medeiros, Exp. Eye Res., 80:761-775

    20051028, Curcio-2

  • Drusen Contain CholesterolCurcio, Presley, Medeiros, Malek, Avery, Kruth Exp Eye Res 2005, in press

    20051028, Curcio-2

  • Drusen Contain ApoBMalek et al, Am J Pathol 162:413 (2003)Apo B immunoreactivityControlAutofluorescence

    20051028, Curcio-2

  • Retina & RPE: Apo B/ MTP PathwaymRNA detected by RT-PCRmRNA sequence: apo B-100ApoB and MTP proteins detected by western blotNative retina & RPE, ARPE-19, and HepG2 cell linesLi, Presley, Zhang, Dashti, Chung, Medeiros,Guidry, Curcio; 2005,J. Lipid Res, 46:628 - 640

    20051028, Curcio-2

  • De novo Neutral Lipid SecretionLi, Presley, Zhang, Dashti, Chung, Medeiros,Guidry, Curcio; J. Lipid Res, 2005, 46:628 - 640

    20051028, Curcio-2

    Table 5. New synthesis and secretion of phospholipids, triglyceride and esterified cholesterol by oleate-BSA- supplemented ARPE-19 cells (dpm/g protein) *

    PL

    TG

    EC

    24 hr Cell

    8431 527

    9728 1019

    47 4

    48 hr Cell

    10889 522

    10350 405

    105 17

    24 hr Medium

    1902 80

    217 5

    137 10

    48 hr Medium

    2258 81

    473 26

    367 65

    * Data are representative of five independent experiments. Cells were incubated with 5 Ci/ml of [3H]oleate (5000 dpm/nmole) bound to 1.5% fatty acid- free BSA.

  • Plasma vs Eye LipoproteinsLi, Chung, Presley, Malek, Zhang, Dashti, Li, Chen, Bradley, Kruth, Curcio; IOVS, 2005, 46:2576-2586

    20051028, Curcio-2

  • ApoB and ApoA-I ExpressionLi, Chung, Presley, Malek, Zhang, Dashti, Li, Chen, Bradley, Kruth, Curcio; 2005, IOVS, 46:2576-2586

    20051028, Curcio-2

  • AbetalipoproteinemiaMIM2001001, Bassen-Kornzweig disease (1950)Autosomal recessive inheritanceNo apo B containing lipoproteins in plasma Fat malabsorption/ steatorrheaAcanthocytosis of red blood cellsAtaxic neuropathy & pigmentary retinopathyCaused by lack of functional MTPAbsence of protein in ABL intestinal biopsy (1992) Null mutation of MTP gene (1993)Variable clinical response to vitamin E (1982-1986)Retinopathy persists, progresses despite long-term supplementation (2001).Retinas can be normal despite absence of plasma vitamin E or abnormal despite normal plasma vitamin ERe-interpretion: ABL is a naturally occurring loss-of-function mutation of MTP at the level of the RPE signifying that lipoprotein assembly is constitutive and important for outer retinal health58-year-old maleHomozygote forS590I missense mutationAl-Shali et alClin Gen 63:135 (2003)

    20051028, Curcio-2

  • Model/ Hypothesis

    20051028, Curcio-2

  • HypothesisAge-related maculopathy, like coronary artery disease, involves the Response-to-Retention of apolipoprotein B-containing lipoprotein particles in a vascular intima, with the twist that the apo B-containing lipoprotein comes largely from the RPE rather than plasma.

    20051028, Curcio-2

  • Acknowledgments

    Curcio LaboratoryDina AveryKelley Bradley Tammy BaileyMelissa ChimentoMark ClarkChuan-Ming Li, MD, Ph.DGoldis MalekLeigh MillicanBrett PresleyLan Wang, MDXueming ZhangOphthalmologyClyde Guidry, PhDMedicineB.H. Chung, PhDNassrin Dashti, PhDLing Li, DVM, PhD

    Retina Specialists of North Alabama Nancy Medeiros, MDNorthwestern UniversityMark Johnson, PhDJiahn-Dar HuangJeff Ruberti, PhDWake Forest UniversityDawn Schwenke, PhDNHLBIHoward Kruth, MD

    20051028, Curcio-2

  • SupportNational Eye InstituteResearch to Prevent Blindness, Inc.International Retinal Research FoundationEyeSight Foundation of AlabamaRoger Johnson Prize in Macular Degeneration ResearchMacula Vision Research Foundation

    20051028, Curcio-2

    For images on the next slide:

    Holz, Sheraidah, Pauleikhoff, and Bird (1994) Arch. Ophthalmol. 112: 402.Fig. 3: composition of lipids extracted from human macular and peripheral Bruchs membrane; mean SD, 32 eyes.

    Sheraidah, Steinmetz, Maguire, Pauleikhoff, Marshall, & Bird (1993). Ophthalmology 100: 47. Fig. 1: Correlateion between age and total lipid extracted from Bruchs membrane in the first series of specimens. Curve is exponential.

    20051028, Curcio-220051028, Curcio-2Curcio, Presley, Medeiros, Malek, Avery, Kruth Exp Eye Res 2005, in press20051028, Curcio-2ARM, like coronary artery disease, involves the Response-to-Retention of apoB-containing lipoprotein particles in a vascular intima, with the twist that the apoB-containing lipoprotein comes largely from the retinal pigment epithelium rather than plasma.

    Each step of this process is a testable hypothesis. I am going to focus on the development of the extracellular lesions, drusen and basal linear deposits.

    20051028, Curcio-2This story begins with important observations made by Dr. Bird and his fellows, Drs. Pauliekhoff and Holz. As described by Pauliekhoff, macular BrM from older adults contains abundant oil red O stained neutral lipid that is largely absent in younger eyes. This lipid was quantified in extracts of BrM and choroid using thin layer chromatography. These studies established that BrM lipids were present in normal eyes, that lipids increased with age, and that they were more prominent in the macula than in the periphery. A 4th study demonstrated oil red O stained lipids in drusen and basal deposits. This is one of the largest age-effects in the human outer retina. Yet for 15 years these findings have been like the elephant in the room-- something very big that no one talks about, except to express the fervent belief that the retinal pigment epithelium is somehow responsible for this. I would submit that this subject has been neglected because up to now there was neither a plausible mechanism to account for the arrival of lipids in Bruchs membrane nor a plausible role for extracellular lipid deposition in the progression of ARM, once they arrived. 20051028, Curcio-250 years into an era of intensive biomedical research, we should be able to find testable hypothesis of pathogenesis that accounts for the overall trajectory of ARM.Because the principal lesions (drusen and basal linear deposit) are in a vessel wall outside the blood-retina barrier, and extracellular lipids accumulate in BrM with age, our thinking should be guided by research on coronary artery disease, another disease featuring extracellular lipid deposition in a vessel wall.

    20051028, Curcio-2Starting with the basics, lipoproteins are multimolecular complexes that solubilize a neutral lipid core (essentially an oil droplet) containing triglyceride and EC, within a 2 nm thick surface of protein, UC, and phospholipid. The major classes are based on flotation properties in density gradient ultracentrifugation. Diameters range from 600 nm for CM to 7 nm for HDL. Outer shell (2 nm) consists of apolipoproteins, UC, PL; spherical neutral lipid core is TG and EC. CM & VLDL have most TG and least protein (1-10%); LDL and HDL have most EC in core and 30-50% proteins. Low density (LDL, 22 nm) Core: EC; Surface: Apo BVery low density (VLDL, 75 nm) Core: TG, EC; Surface: Apo B, E, CIIIChylomicrons (>75 nm) Core: TG, EC; Surface: Apo B, E, CIII, ATG-rich lipoproteins are large, produced by the liver (VLDL) and intestine (chylomicrons), and contain apolipoprotein B.Apolipoproteins act as co-factors for enzymes & ligands for cellular receptors. The lipoproteins that initiate atherosclerotic cardiovascular disease contain a single molecule of apoB, one of the largest of plasma proteins.ApoB-100 from liver and apoB-48 from intestine are products of the same gene, and apoB48 is produced by editing of the full-length mRNA.Top Left: Vance JE: Assembly and secretion of lipoproteins. Biochemistry of Lipids, Lipoproteins and Membranes. Edited by Vance DE, Vance JE. Amsterdam, Elsevier, 2002, pp 505-526, Figure 1Main Figure: Jonas, A. (2002). Lipoprotein structure. Biochemistry of Lipids, Lipoproteins and Membranes. D. E. Vance and J. E. Vance. Amsterdam, Elsevier. 36: 483-504. Lipoproteins are separable by their density, size, charge, and the composition of their core and surface components.20051028, Curcio-2Cholesterol, exists in two chemical formsunesterified (free), which I will call UC, and is present in all eukaryotic membranesOr bound by an ester linkage to a fatty acid at the 3-beta-hydroxy group to produce esterified cholesterol, which I will call EC. Esterified cholesterol is the storage and transport form and forms part of the neutral lipid core.20051028, Curcio-2Lusis AJ, Fogelman AM, Fonarow GC. Genetic basis of atherosclerosis: part I: new genes and pathways. Circulation. 2004;110:1868-73.Lipids are transported through the circulation as complexes with various apolipoproteins that package lipids and act as cofactors for enzymes or ligands for uptake by cellular receptors. Dietary lipids are absorbed in intestine, packaged into chylomicrons, and secreted into lymph. On entering circulation, triglycerides are hydrolyzed through action of LPL and the resulting remnants taken up by interaction of apoE with LDL receptor (apoB, E receptor) or LRP. During lipolysis, surface phospholipids and chylomicron proteins slough off to give rise to HDL precursors. Liver cells package triglycerides and cholesterol esters into VLDL particles. LPL acts on them, hydrolyzing TG to release fatty acids to produce intermediate-density lipoproteins (IDL), which can be taken up by B, E-receptor, or further lipolyzed, partly through hepatic lipase (HL) action, to produce LDL. LDL retains a single major protein, apoB100, and is removed from circulation by the apoB, E receptor. Because of slow kinetics of LDL uptake, LDL particles constitute major cholesterol-carrying particle in most individuals. LDL can complex with apo(a) protein to form Lp(a) particles, which appear par-ticularly atherogenic. Mature, spherical HDLs are formed largely in the circulation from apoAI and AII secreted by liver and intestine and from chylomicrons surface and VLDL during their lipolysis. HDL precursors take up cholesterol from various tissues through interaction with ABCA1 transporter, and cholesterol is esterified by lecithin:cholesterol acyl transferase (LCAT) action. Lipids can be transferred between lipoproteins through the actions of cholesteryl ester transfer protein (CETP) and phospholipid transfer protein (PLTP).20051028, Curcio-2Glycoprotein, very large, prone to degradation, insoluble when delipidated, sedimentation velocity and molecular weight determinations very dependent on concentration of solution.

    Segrest JP, Jones MK, De Loof H, Dashti N: Structure of apolipoprotein B-100 in low density lipoproteins. J Lipid Res 2001, 42:1346-1367.Top Fig. 2. Schematic diagram of the pentapartite structural model, NH3- ba1- b1- a2- b2- a3-COOH, for apoB-100.Upper: the five domains defined previously (35, 44) have been modified as follows: first, the N-terminal a1 (globular) domain, based upon homology to lipovitellin (59), has been expanded to encompass residues 1 1,000 and, because of the presence of both amphipathic a-helical and b-strands in the sequence, renamed the a1 domain. Thus, the b1 domain has been shortened to encompass residues 1,0012,000. Bottom Fig. 1. Schematic diagram of the structure of apoB-100 on the surface of LDL. Trypsin-releasable and trypsin-nonreleasable regions are shown on the inside and outside of the LDL surface, respectively. The five proposed domains are demarcated by dashed lines. The two thrombin-cleavable sites are marked at residues 1,297 and 3,249. Open circles represent N-glycosylated carbohydrates, and shaded circles represent cysteine residues. Apo B-100 (4536 residues) is produced in the liver as VLDL. Apo B-100 has 5 domains with globular, -helical amphipathic, and -sheets. Apo B-48 (2152 residues) is produced in the small intestine as dietary chylomicrons. Apo B-100 and apo B-48 are products of the same gene, with apo B48 arising from post-transcriptional editing of apo B-100 mRNA. Successful transfer of lipids to nascent apo B regulates whether apo B is secreted in a mature lipoprotein particle or degraded via the ubiquitin-proteasome system.20051028, Curcio-2Segrest JP, Jones MK, Dashti N: J Lipid Res 1999, 40:1401-1416. Fig. 7. Lipid pocket model for assembly of apoB-containing lipoprotein particles. Lipoproteins are assembled not synthesized. An incomplete lipid pocket is formed by amphipathic b strands (blue dashes) located in the a1 domain of hAPOB. MTP is required for this pocket to fill with lipid (yellow, neutral lipid; light blue, phospholipid head groups; black,fatty acyl chains), perhaps acting as a co-structural element to complete the pocket (see C). Once the pocket is filled, additional amphipathic b strands from the b1 domain of hAPOB are co-translationally added, allowing the lipid pocket to expand until defined lipoprotein particles with HDL, then VLDL density result.

    20051028, Curcio-2The Response to Retention hypothesis of atherosclerotic states that coronary artery disease is a Response-to-Retention of apoB-containing lipoproteins from plasma in the arterial intima. This hypothesis summarized 8 decades of research, culminating in the late 1980s and early 1990s establishing that the earliest and largest cholesterol component in the lipid-rich core derives from plasma apo B-containing lipoproteins that directly infuse into intima. These are apoB-100 containing VLDL from liver, and its metabolite LDL, and apoB-48 containing dietary chylomicrons from intestine and their partly hydrolyzed remnants. Lipoprotein particles enter intima via endothelial cell trancytosis and bind to specific proteoglycan molecules(such as biglycan and versican). Retained lipoproteins are modified by oxidative and non-oxidative processes, evoking a cascade of downstream events. These include deposition of cholesterol, foam cell formation, proliferation of smooth muscle cells, endothelial cell injury, cytokine release, neovascularization, thrombosis, and inflammation. Williams KJ, Tabas I: Arterioscler Thromb Vasc Biol 1995, 15:551-561; Born J et al J Clin Invest 1998, 101:2658-2664.; Williams KJ, Tabas I: Curr Opin Lipidol 1998, 9:471-474; Sklen K et al: Nat Med 2002, 417:750-754. Figure modeled after Proctor et al. Curr Opin Lipidol 2002, 13:461-470.20051028, Curcio-2Curcio, C.A., C.L. Millican, T. Bailey, and H.S. Kruth (2001) Accumulation of cholesterol with age in human Bruch's membrane. Invest. Ophthalmol. Vis. Sci. 42: 265-274, Figure 3.

    We used the cholesterol-specific fluorescent marker filipin and digital fluorescence microscopy to determine whether the oil red O staining material in human Bruchs membrane includes EC. Filipin binds to UC but in tissue that is extracted and hydrolyzed with cholesterol esterase it binds to UC that is newly released. We found that normal human Bruchs membrane markedly accumulates EC in the macula throughout adulthood. Accumulation occurs in the periphery but about 7-fold less. Similar results were found for UC. 20051028, Curcio-2Curcio, C.A., C.L. Millican, T. Bailey, and H.S. Kruth (2001) Accumulation of cholesterol with age in human Bruch's membrane. Invest. Ophthalmol. Vis. Sci. 42: 265-274.

    In order to determine the ratio of EC and UC, we assayed cholesterol by enzymatic fluorimetry in extracts of partially isolated BrM preparations. From 8 mm diameter punches for preserved maculas >70 yr, we found that 60% of the cholesterol recovered was esterified. Less than 6% of it could be accounted for by plasma lipoproteins remaining in choriocapillaries.BrM EC is therefore 17-40-fold enriched relative to plasma.20051028, Curcio-2Since the 1960s eye researchers have noted electron-lucent profiles in BrM and called them vesicles, that is, liposomes with aqueous interiors.15 years ago it was shown that normal and atherosclerotic arterial intima accumulates 100 nm diameter particles rich in EC. Using the same lipid-preserving ultrastructural methods used in intima, we determined that the electron-lucent droplets visible by conventional EM {shown here} were not vesicles but rather solid lipid containing particles {shown here}.We further determined that these particles are extractable with lipid solvents. In foveal BrM of older adults, they occupied 30% of the volume of inner BrM and formed a dense band 3-4 droplets thick external to the RPE basal lamina. 20051028, Curcio-2Ruberti JW, Curcio CA, Millican CL, Menco BPM, Huang J-D, Johnson M: Quick-freeze/deep-etch visualization of age-related lipid accumulation in Bruchs membrane. Invest Ophthalmol Vis Sci 2003, fig. 5

    In a collaboration with Jeff Ruberti in Mark Johnsons lab at Northwestern University, we compared transmission EM and quick-freeze deep etch preparations of the same maculas. We called this band the lipid wall, shown here dramatically by conventional and QFDE methods in an eye from a 41 year old donor and a 76 year old donor. The older eye contains a tightly-packed layer of space-filling particles (C) that displace the structural collagen fibers present at the same location in the younger eye (A). The electron lucent particles seen in thin-section transmission EM (C) correspond to solid particles seen in QFDE (D).

    20051028, Curcio-2QFDE also revealed detail of of individual lipid particles in Bruchs membrane. These are collagen fibrils viewed end-on. The lipid rich particles have a surface and core substructure, resembling lipoproteins.

    Ruberti JW, Curcio CA, Millican CL, Menco BPM, Huang J-D, Johnson M: Quick-freeze/deep-etch visualization of age-related lipid accumulation in Bruchs membrane. Invest Ophthalmol Vis Sci 2003, Fig. 5. 20051028, Curcio-2We further examined lesions in ARM eyes processed with the OTAP post-fixation method. The question was whether membranous debris, described by Shirley Sarks as the principal component of basal linear deposit, was membranes, or another form of lipid, poorly preserved. Here we addressed whether membranous debris resembles plasma membranes delimiting local cellular processes.

    Figure 3: membranous debris differs from cellular processes. Bars = 0.5 m. A. Distorted electron-dense web-like material (single arrow) contrasts with basal infoldings (double arrowhead) of RPE (R), which have a less dense exterior and a more homogeneous interior; glutaraldehyde/paraformaldehyde, OTAP. Black arrowheads indicate RPE basal lamina. B. An electron-dense web-like material (single arrow) extends throughout a thick basal deposit but contrasts in density and form from basal infoldings (double arrowheads) of RPE (R); paraformaldehyde, OTAP. C. In processes of presumed Mller cells (double arrowheads) within BlamD (asterisk) in eyes with severe RPE atrophy and photoreceptor loss, plasma membranes are not electron-dense,; glutaraldehyde/paraformaldehyde, 2% osmium. Black arrowheads indicate RPE basal lamina. D. Individual profiles in a sub-RPE aggregate of membranous debris (arrowheads) are enlarged and partially extracted by processing; glutaraldehyde/paraformaldehyde, 2% osmium. E. Individual profiles in a similar sub-RPE aggregate of the same eye as D are solid and surrounded by an electron-dense band; glutaraldehyde/paraformaldehyde, OTAP. 20051028, Curcio-2In fellow eyes with ARM, shown here post-fixed by 2% osmium (left) and OTAP (right) ultrastructural methods, electron-lucent particles in basal laminar deposits are actually solid lipid-containing particles that are also abundant in the layer of basal linear deposits.

    Figure 6: Droplets in basal laminar and BlinD are solid particles, in eyes with late Ex-ARM. A. Lipid particles appear as electron-lucent spaces (arrows) of varying diameter. glutaraldehyde/paraformaldehyde, 2% osmium. B. In the fellow eye, lipid particles are solid (arrows). Arrowheads denote RPE basal lamina, which overlies BlinD. paraformaldehyde, OTAP. Bar = 0.5 m.

    Other eyes showed pools of neutral lipid rather membranous coils in a layer of basal linear deposits. 20051028, Curcio-2Figure 2. Cholesterol-containing macular drusen in eyes with ARM. Bright field (A,C,E,G,I) and filipin fluorescence images (B,D,F,H, and J) of the same drusen in hematoxylin-counterstained cryosections. UC, unesterified cholesterol; EC, esterified cholesterol; wide-field epi-fluorescence and 35 mm film; bar in J = 20 m. A,C show confluent drusen containing abundant UC (B) and EC (D) in Case 15 (see caption for Figure 1). UC in cellular membranes of the neurosensory retina, RPE, and choroid also binds filipin (B). Arrowheads in A indicate Bruchs membrane. E,G show two confluent hard drusen, partly detached from BrM, in Case 1. The left druse has more UC (F) and EC (H) than the right druse. I shows a detached soft druse with putative membranous debris, corresponding to loops of UC-containing material (J) in Case 3. Panel J is focused to reveal druse contents. Out-of-focus RPE membranes form a haze around the druse interior.

    20051028, Curcio-2Malek, G., C.-M. Li, C. Guidry, N.E. Medeiros, and C.A. Curcio (2003) Apolipoprotein B in cholesterol-containing drusen and basal deposits in eyes with age-related maculopathy. Am. J. Pathol. 162: 413-425, Figure 4.In addition to cholesterol we also localized apoB immunoreactivity in inner BrM and in drusen. No label appeared in control sections, and the pattern of specific immunoreactivity distinctly differed from that of autofluorescence in the same section. In peripheral retina of normal eyes where we could get a large enough sample, as many drusen contained apoB as apoE, previously established as a druse constituent by Anderson, Hageman, and colleagues. Fig. 4: Apo B immunofluorescence and autofluorescence in cryosections of normal and ARM eyes. Sections were probed with polyclonal anti-apo B (A,B,D,E) or non-immune serum (C,F). Images were obtained with a 40X plan fluor oil objective and either a rhodamine filter set (A,C,D,E) or an autofluorescence filter set (B,E). A-C, normal , macula, 87-year-old man. D-F, ARM, periphery. A. Apo B immunoreactivity is present in Bruchs membrane (BrM), especially on the inner aspect (arrowhead). RPE is autofluorescent (*). B. In the same section as A, autofluorescence in BrM is distributed differently from the specific fluorescence in A. C. No fluorescence is detected in BrM of a control sections at the same exposure time as A. D. Apo B immunoreactivity is present in a druse. E. In the same section as D, autofluorescence is present in RPE and BrM and within the druse, in a different pattern from D. F. No fluorescence in a druse in a control section.20051028, Curcio-2Is there evidence for local expression of apoB, and more importantly, MTP?

    These data show evidence for mRNA for apoB, MTP, and PDI in neurosensory retina, native and cultured RPE, and HepG2, a human hepatoma cell line. No evidence for expression of APOBEC-1, which edits mRNA in the process of apoB-48 synthesis.

    Accordingly, the sequence of the mRNA for RPE apoB was the full-length hepatic form, not the shortened intestinal form.

    Finally apoB protein was found in native and cultured RPE, as was the 97KD large subunit of MTP.

    Cells that express MTP, which are found in liver, intestine, and heart, do so for one reason only -- because they are in the business of assembling and secreting apoB containing lipoproteins. 20051028, Curcio-2A standard paradigm for achieving secretion of apoB lp in culture has been used for HepG2 hepatoma cells for almost 20 yr. This entails supplementing serum-starved cells with radiolabled oleic acid bounds to fatty acid-free bovine serum albumin. Following this stimulation, at 24 or 48 hr intervals, lipids were extracted, separated by thin layer chromatography and quantified by liquid scintillography. These experiments showed that ARPE-19 cells was capable of synthesizing and secreting TG, EC, and PL. Negative stain EM shows plasma VLDL and particles isolated by centrifugation (d